Correlation Between Connect Biopharma and Uniqure NV
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Uniqure NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Uniqure NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Uniqure NV, you can compare the effects of market volatilities on Connect Biopharma and Uniqure NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Uniqure NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Uniqure NV.
Diversification Opportunities for Connect Biopharma and Uniqure NV
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Connect and Uniqure is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Uniqure NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uniqure NV and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Uniqure NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uniqure NV has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Uniqure NV go up and down completely randomly.
Pair Corralation between Connect Biopharma and Uniqure NV
Given the investment horizon of 90 days Connect Biopharma Holdings is expected to under-perform the Uniqure NV. But the stock apears to be less risky and, when comparing its historical volatility, Connect Biopharma Holdings is 1.32 times less risky than Uniqure NV. The stock trades about -0.17 of its potential returns per unit of risk. The Uniqure NV is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 644.00 in Uniqure NV on August 24, 2024 and sell it today you would lose (59.00) from holding Uniqure NV or give up 9.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Connect Biopharma Holdings vs. Uniqure NV
Performance |
| Timeline |
| Connect Biopharma |
| Uniqure NV |
Connect Biopharma and Uniqure NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Connect Biopharma and Uniqure NV
The main advantage of trading using opposite Connect Biopharma and Uniqure NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Uniqure NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uniqure NV will offset losses from the drop in Uniqure NV's long position.| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
| Uniqure NV vs. Rocket Pharmaceuticals | Uniqure NV vs. Rhythm Pharmaceuticals | Uniqure NV vs. Solid Biosciences LLC | Uniqure NV vs. MeiraGTx Holdings PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |